University of Sydney awarded more than $82 million in National Health & Medical Research Council (NHMRC) grants
In the announcement made today by the federal government the University achieved 102 funding awards from $630 million given nationally to 2000 researchers.
“This is an excellent outcome for the University that builds on our strengths and affirms the relevance and value of our research and the quality of our collaborations across the health and medical spectrum. This research has the potential to save or improve the lives of countless individuals,” said Professor Duncan Ivison, Deputy Vice-Chancellor (Research).
“The grants include nine for career development fellowships, the highest number awarded. They include research on bioinformatics to treat complex diseases, regenerative neuroscience strategies for healthy brain ageing and dementia, and the development of low-cost, low-radiation screening to prevent cardiovascular disease.”
The funding has secured 11 early career fellowships in areas as diverse as improving the early detection of bipolar disorder in individuals seeking treatment for depression, investigating the causes and prevention of cerebral palsy, and optimising value and equity in access to prescribed medicines.
More than $6 million will fund eight research fellowships investigating:
- innovations in cancer imaging and targeted radiotherapy to improve human health
- how developmental genomics and embryology can improve our understanding of birth defects and rare genetic disorders
- advancing the treatment of sleep disorders including sleep apnoea and insomnia
“These results, along with our emerging University strategic plan, give us a strong basis upon which to build and do even better in the future,” Professor Ivison said.
This article appeared on The University of Sydney website. The University of Sydney is one of four major shareholders of ATP Innovations – including the Australian National University, the University of Technology Sydney, and the University of New South Wales.